<DOC>
	<DOCNO>NCT01876251</DOCNO>
	<brief_summary>This study aim determine tolerability PF-03084014 plus docetaxel combination patient advance breast cancer . Preliminary information efficacy combination also collect .</brief_summary>
	<brief_title>A Study Evaluating The PF-03084014 In Combination With Docetaxel In Patients With Advanced Breast Cancer</brief_title>
	<detailed_description />
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Docetaxel</mesh_term>
	<criteria>Diagnosis breast cancer evidence ) metastatic b ) locally recurrent/advanced disease . Prior treatment gamma secretase inhibitor Notch signal inhibitor .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2016</verification_date>
	<keyword>Breast cancer metastatic</keyword>
	<keyword>docetaxel</keyword>
	<keyword>PF-03084014</keyword>
</DOC>